NM_033360.4:c.34_36delGGTinsCGC
Variant summary
The NM_033360.4(KRAS):c.34_36delGGTinsCGC (p.Gly12Arg) variant causes a missense change. Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.89). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.G12C: Likely_pathogenic (ClinVar VariationId 12578, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.G12= (synonymous): Likely_benign (ClinVar VariationId 1734094, 1 star); p.G12= (synonymous): Likely_benign (ClinVar VariationId 4859020, 1 star); p.G12= (synonymous): Likely_benign (ClinVar VariationId 1734090, 1 star) The same amino acid change has been reported as oncogenic or likely oncogenic in a clinical somatic variant database. The variant position is a cancer hotspot (cancerhotspots.org): 2910 samples carry this exact amino acid change out of 32010 samples with a variant at this residue. This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Juvenile myelomonocytic leukemia (jmml); it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_033360.4 missense
Scores
Clinical Significance
Conservation
Publications
- cardiofaciocutaneous syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Noonan syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- autoimmune lymphoproliferative syndrome type 4Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- cardiofaciocutaneous syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
- linear nevus sebaceous syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 15 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS1Same amino acid change as known pathogenic | Same AA change, ≥2-star ClinVar pathogenic — very strong (PS1); ClinVar contains 1 P/LP entry with the same amino acid change (highest review level: 2 stars). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 16 pathogenic, 0 benign (OR vs. background: 165.0). | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (threshold 0.0001) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.G12C: Likely_pathogenic (ClinVar VariationId 12578, 1 star); Other variants at the same amino acid residue (not pathogenic): p.G12= (synonymous): Likely_benign (ClinVar VariationId 1734094, 1 star); p.G12= (synonymous): Likely_benign (ClinVar VariationId 4859020, 1 star); p.G12= (synonymous): Likely_benign (ClinVar VariationId 1734090, 1 star) | ||
| PP2Missense in gene with low missense rate | Missense in gene constrained for missense variation where missense is common disease mechanism (PP2); Missense in a gene constrained for missense variation (gnomAD Z-score: 3.090). ClinVar shows strong pathogenic missense enrichment: 82 P/LP and 6 B/LB missense entries (ratio 13.7×). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_033360.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KRAS | MANE Plus Clinical | c.34_36delGGTinsCGC p.Gly12Arg | missense | N/A | Prot: NP_203524.1 UniProt: | |
KRAS | MANE Select | c.34_36delGGTinsCGC p.Gly12Arg | missense | N/A | Prot: NP_004976.2 | |
KRAS | c.34_36delGGTinsCGC p.Gly12Arg | missense | N/A | Prot: NP_001356715.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KRAS | TSL:1MANE Plus Clinical | c.34_36delGGTinsCGC p.Gly12Arg | missense | N/A | Prot: ENSP00000256078.5 UniProt: | |
KRAS | TSL:1MANE Select | c.34_36delGGTinsCGC p.Gly12Arg | missense | N/A | Prot: ENSP00000308495.3 UniProt: | |
KRAS | TSL:1 | c.34_36delGGTinsCGC p.Gly12Arg | missense | N/A | Prot: ENSP00000451856.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 2 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
PhyloP100 | Pathogenic | 7.9 |
Splicing Scores
No splicing scores have been computed for this variant.
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- KRAS
- Score
- -0.845 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- -0.253 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- -0.526 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- -0.271 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- -0.132 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- 1.12 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- 0.192 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- 0.398 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- -0.283 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- 0.341 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- -0.359 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- 0.236 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- 0.588 · p.Gly12Arg (assay numbering)
- Gene
- KRAS
- Score
- 0.497 · p.Gly12Arg (assay numbering)